ICH GCP (R3) Training Materials Now Available for Investigators and Site Personnel
August 22, 2025 — ClinChoice is proud to announce that as of August 18, 2025, we have officially joined the TransCelerate “GCP Training Mutual Recognition” Initiative. This step highlights our ongoing commitment to uphold globally recognized Good Clinical Practice (GCP) standards and enhance efficiency, compliance, and quality in clinical trial operations.
The initiative, led by TransCelerate BioPharma Inc., a non-profit organization established in 2012 by leading biopharmaceutical companies, aims to streamline GCP training across the industry. It facilitates mutual recognition of standardized, high-quality GCP training programs for investigators and site personnel involved in clinical trials.
ClinChoice is now listed among the recognized training providers on the TransCelerate website, offering ICH GCP (R3) Training that meets the initiative’s rigorous criteria.
“Being part of the TransCelerate GCP Training Mutual Recognition Initiative is an important milestone for ClinChoice,” said James Liu, Vice President of Quality & Strategy at ClinChoice. “It reinforces our dedication to quality, compliance, and the global harmonization of clinical trial practices, ensuring our partners and sites can rely on consistent, trusted training resources.”
We remain dedicated to serving as your trusted clinical trial partner, continuously advancing quality and standardization in all our operations.
About ClinChoice
ClinChoice is a leading global full & functional service CRO, renowned for its exceptional product development and lifecycle management capabilities across the pharmaceutical, biotechnology, medical device, and consumer health sectors. With three decades of proven expertise and outstanding results, we excel in delivering top-tier services.
Our deep regulatory expertise, clinical trial execution, and robust pharmacovigilance and biometrics capabilities position us as a trusted partner in global markets. ClinChoice proudly maintains a strong presence across the Americas, Europe, and Asia-Pacific, ensuring comprehensive support for our clients worldwide.